中文名稱:3344-18-1檸檬酸鎂 其他中文名稱: 枸櫞酸鎂;2-羥基-1,2,3-丙三羧酸鎂鹽 英文名稱: Magnesium citrate tetradecahydrate 其他英文名稱: 2-Hydroxy-1,2,3-propanetricarboxylic acid magnesium salt (2∶3);Citramag 產(chǎn)品規(guī)格: CP,98% 包裝:500克 :3344-18-1 C12H10Mg3O14·14H2O=703.33 級(jí)別:CP 含量:98.0~102.0% 氯化物:≤0.005% 硫酸鹽:≤0.01% 鹽酸不溶物:≤0.05% 重金屬:≤0.003% 鐵:≤0.003% 性狀:結(jié)晶性粉末或顆粒。無氣味。溶于稀酸,微溶于水。檸檬酸和其鉀鹽或鈉鹽可增加其溶解度。 用途:生化研究。食品添加劑。分析試劑。制藥工業(yè) 保存:RT
3344-18-1檸檬酸鎂儲(chǔ)存條件: 避光、干燥陰涼處封閉貯存,嚴(yán)禁與有毒、有害物品混放、混運(yùn)。本品為非危險(xiǎn) 產(chǎn)品可按一般化學(xué)品運(yùn)輸,輕搬動(dòng)輕放,防止日曬、雨淋!受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運(yùn)輸條件比較苛刻 運(yùn)用經(jīng)典檢測(cè)方法(高效液相色譜法),檢測(cè)數(shù)據(jù)誤差小,高純度含量讓實(shí)驗(yàn)結(jié)果更精確。符合產(chǎn)品質(zhì)量標(biāo)準(zhǔn),各項(xiàng)指標(biāo)檢測(cè)齊全。使用范圍廣泛,品牌供應(yīng),用的放心。國(guó)家重點(diǎn)實(shí)驗(yàn)室產(chǎn)品,實(shí)驗(yàn)效果讓您實(shí)實(shí)在在看的見。 Anti-IKB beta 核因子κB抑制蛋白β抗體 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-HSP-90 Beta/FITC 熒光素標(biāo)記HSP-90β蛋白抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies TRAIL/Apo2L (tumor necrosis factor-related apoptosis-inducing ligand) 腫瘤壞死因子相關(guān)凋亡誘導(dǎo)配體/凋亡素2配體抗原 規(guī)格: 0.5mg 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Rat Slit2 ELISA Kit 大鼠Slit2 規(guī)格: 96T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-P-AKT1/PKB1/2/3(pSer473) /FITC 熒光素標(biāo)記磷酸化蛋白激酶B(pSer473)抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-Phospho-PEA15 (Ser116) 磷酸化星形膠質(zhì)細(xì)胞PEA15抗體 規(guī)格: 0.1ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-Phospho-PDGF Receptor alpha (Tyr1018)/FITC 熒光素標(biāo)記磷酸化血小板源性生長(zhǎng)因子受體-α抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies CXCL16(Human CXC-chemokine ligand 16) ELISA Kit 人CXC趨化因子配體16 規(guī)格: 48T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-apo-D /FITC 熒光素標(biāo)記載脂蛋白D抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-phospho-AMPK beta 1(Ser182) 磷酸化腺苷單磷酸活化蛋白激酶β1抗體 規(guī)格: 0.1ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-Acinus(phospho S1180)/FITC 熒光素標(biāo)記腺泡磷酸化Acinus抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Rabbit Anti-dog IgG/HRP 辣根過氧化物酶標(biāo)記兔抗狗IgG 規(guī)格: 0.1ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies MAPKAPK3(Human mitogen-activated protein kinase-activated protein kinase 3) ELISA Kit 人促分裂素原活化蛋白激酶激活的蛋白激酶3 規(guī)格: 48T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-Phospho-EGFR(Tyr845) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化表皮生長(zhǎng)因子受體抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-EGF 表皮生長(zhǎng)因子抗體 規(guī)格: 0.1ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-DDX4/MVH/FITC 熒光素標(biāo)記DDX4抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies CK1/8/19 (Cytokeratin1/8/19; Keratin 1/8/19)peptide 細(xì)胞角蛋白1/8/19抗原 規(guī)格: 0.5mg 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies LTE4 ELISA Kit 大鼠白三烯E4 規(guī)格: 48T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-p44/42 MAPK (phospho Thr202/Tyr204) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化絲裂原活化蛋白激酶1/2抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-LFABP/FABP-2 肝臟型脂肪酸結(jié)合蛋白抗體 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-LAP18/stathmin/FITC 熒光素標(biāo)記白血病相關(guān)蛋白18/癌蛋白18抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies GABA/BSA γ1氨基丁酸偶聯(lián)牛血清白蛋白 規(guī)格: 1mg 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Cyclin-D3(Mouse Cyclin-D3) ELISA Kit 小鼠細(xì)胞周期素D3 規(guī)格: 48T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-phospho-Src (Tyr418)/FITC 熒光素標(biāo)記磷酸化Src原癌基因抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies Anti-Phospho-SGK1 (Ser78) 磷酸化糖皮質(zhì)激素調(diào)節(jié)激酶1抗體 規(guī)格: 0.1ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies 3344-18-1檸檬酸鎂Anti-S100A13/FITC 熒光素標(biāo)記鈣結(jié)合蛋白S100A13抗體IgG 規(guī)格: 0.2ml 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies GCA(Human gastrin cell antibody) ELISA Kit 人胃泌素細(xì)胞抗體 規(guī)格: 48T 進(jìn)口/國(guó)產(chǎn) Multi-class antibodies 公司提供的3344-18-1檸檬酸鎂*,貨源充足。嚴(yán)格的質(zhì)量控制體系,包括:優(yōu)級(jí)純,分析純,化學(xué)純,試劑級(jí),基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純?cè)噭V純,光譜純,電子純。各種包裝規(guī)格,并可提供包裝定制,咨詢訂購(gòu)。
|